Mometasone Nasal Spray (Mometasone Furoate)

Adult use

1. Allergic Rhinitis (Rhinitis) Adults (including older patients) and adolescents aged 12 and older: Generally administer 2 sprays into each nostril once a day (total daily dosage 0.2 mg). If symptoms are alleviated, the maintenance dosage can be reduced to 1 spray in each nostril (total daily dosage 0.1 mg). If symptoms are not alleviated, the dosage can be increased to 4 sprays in each nostril once a day (total daily dosage 0.4 mg). 2. Nasal Polyps Generally administer 2 sprays into each nostril once a day (total daily dosage 0.2 mg). If symptoms do not improve after 5 to 6 weeks, the dosage may be increased to 2 sprays into each nostril twice a day (total daily dosage 0.4 mg), with a recommendation to reduce the dosage if symptoms improve. If symptoms do not improve after 5 to 6 weeks of twice-daily administration, consider other treatment options. There are no studies using this medication for nasal polyps for over 4 months. 3. Acute Rhinosinusitis Generally administer 2 sprays into each nostril twice a day (total daily dosage 0.4 mg).

Child use

1. Allergic Rhinitis (Rhinitis) Children aged 2 to 11: Generally administer 1 spray into each nostril once a day (total daily dosage 0.1 mg).

This medication may not be suitable for certain patients. It should not be administered to anyone who is allergic to this drug or its components or has previously experienced hypersensitivity reactions. Patients with untreated infections in the nasal mucosa, those who have recently undergone nasal surgery, or those with wounds in the nose should also avoid using this medication. Children under 2 years of age should not use this medication, particularly. Patients with respiratory tuberculosis or severe systemic infections, as well as those with herpes simplex in the eyes, should use this medication with caution, as frequent nosebleeds may worsen. Additionally, those at risk of chickenpox or measles or who have unilateral nasal polyps or cystic fibrosis-related nasal polyps need to use this medication carefully, as its effects have not been sufficiently studied. Women who are pregnant, may become pregnant, or are breastfeeding should consult a physician before using this medication. While using this medication, side effects such as headaches, viral infections, pharyngitis, nosebleeds, cough, and upper respiratory infections may occur, and in some patients, side effects can be severe enough to require discontinuation of the medication. Rarely, rashes, nasal irritation, liver dysfunction, headaches, blood parameter changes have been reported, and nasal ulcers or candidiasis may occur upon nasal use, necessitating consultation with a doctor if symptoms persist. This medication is to be used only intranasally, and care must be taken not to spray directly into the eyes or nasal septum. Prolonged high-dose use may result in systemic side effects, thus regular check-ups are necessary. Since there is a risk of exposure to chickenpox or measles while using this medication, prior medical history or vaccination status should be confirmed, and if infection is suspected, immediate consultation with healthcare professionals is advised. When used for children, growth may be affected, so regular monitoring of growth status is necessary, especially for those under the age of 2 for whom safety has not been established. Elderly patients may have decreased bodily functions and should be closely monitored while using this medication. In the case of overdose, specific treatment is generally not required; however, excessive use may affect adrenal function, so caution is advised. Before use, shake the container well and perform a test spray. After use, the specified number of sprays should be followed, or it should be discarded after 2 months. Keep out of reach of children, and effects on driving or machine operation are not known.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden severe headaches, thunderclap headaches, seizures, altered consciousness, visual disturbances, paralysis.

Mild side effects

Headaches, viral infections, pharyngitis, nosebleeds/blood-tinged mucus, cough, upper respiratory infections, menstrual discomfort, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, ear pain, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), positive fungal tests.

This medication must be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 2 degrees and 25 degrees Celsius. This helps to preserve the effectiveness of the medication and prevent deterioration.

Appearance

An opaque suspension that is white or almost white, contained in a spray bottle that dispenses a fixed amount.

Package unit

18 mL/bottle